半年度财务报告presentation.docVIP

Financial meeting With Andreas Winkler, Zhen Xiao 2009 June 29 --Profit budget comparison --Balance Sheet Review --Internal Audited Financial report --Cash Flow Management --Other discussion Profit budget comparison Pls understand that activity pl report based on performance as per June 26.Pls refer file finace report\pl0906-090626.xls Brief 2009 PL budget comparison (Unit: RMB) Description Balance Budget2009 Budget Reach ratio (2009.1-6) (2009.1-6) Revenue from main operations -49,646,880.96 -65,000,000.00 76% Taxes and surcharge for main operations 33,616.64 30,000.00 112% Cost of main operations 32,404,814.72 48,750,000.00 66% Margin ratio 34.73% 25.00% 　 SEL 6,030,797.72 5,821,360.78 104% GA 3,020,477.39 3,423,072.74 88% Finance Expense -25,400.75 80,000.00 　 RMB RPOFIT before tax -8,182,574.89 -6,895,566.23 119% income tax 25% 1,670,671.95 1,723,890.64 　 RMB RPOFIT After tax -6,511,902.94 -5,171,675.59 126% Pls note the main performance index marked in red. According with the main economic stream in the first half year in china,the first half year witnesses the recovering of domestic economic requirement ,the stable light industry growth . The macro economic gives us chance to accomplish sales performance 50million approaching budget 65 million ,with reach ratio 76% Margin ratio exceeds 9.7% higher than budget 25%, which mainly from the growing localizing manufacturing .Cause we keep or enlarge OEM and Pharma market ,the bio Pharma diaphragm valve contribute the main margin for whole company. Pls refer file 090629\margin-090531.xls Product Group sales till 09 .05 sales percentage margin ratio Pharma Bio 12,820,000 31% 50% 63 industrial metal butterfly valve 11,870,323 29% 31% 62 industrial metal globe, control v. 6,635,543 16% 30% 61 industrial metal diaphragm valve 3,464,477 9% 31% For comparing margin in 2008,pls refer..\..\..\桌面\090629\margin-081231.xls The localization manufacturing also comes from l